Skip to content

Venture

LOGO 2-01

Technologies

Therapeutic

Indication

Cardiovascular Disease

Molecular Diagnostic

We have discovered a microRNA, miR-30c, which lowers plasma cholesterol and atherosclerosis in mice. We would like to commercialize it as a drug to treat hyperlipidemia and atherosclerosis.

Chylos, Inc. Team:

Mahmood Hussain